Why We Get Cancer

Article

People respond to cancer in a number of ways, but blaming the patient should never be one of them.

I will never stop being amazed at the stupid things people say about cancer and why people get it. I have to remind myself that it’s a defense mechanism. Their thinking must be something like this:

“If I can figure out what this person did to get cancer, then I won’t get it.”

A case in point. A young man I worked with was diagnosed very suddenly with advanced colon cancer. The doctor told him he had had it for four years when he was diagnosed — and the cancer had already metastasized. He died at 31.

Discussing this with some colleagues, one of them said. “Well, colon cancer has been linked to a low-fiber diet.”

Come on. This young man was only 31 when he died. Could a diet of only fried food have really killed him — even if that was the reality. If that’s so then I know about 200,000 people in East Texas who are living on borrowed time.

I’m sorry, but I have been in parts of this country where trying to find something green to eat was like searching for the holy grail.

If diet alone could kill someone this quickly we would be seeing whole families — heck, whole states – die of the same disease at a young age. Come to think of it, fiber wasn’t something my family ate when I was young. My father lived on steak and potatoes. He died at 82.

It’s the same logic I hear applied to women who get breast cancer. “She must have had a high-fat diet, or she had her babies late in life, or she didn’t exercise.” But we all know women who fit into all three of these categories and didn’t get breast cancer.

Explain to me why Martha, a vegetarian all her life and a marathon runner, got cancer. Duh.

But people who haven’t had cancer continue to blame the disease on the person who got it.

Have there been proven cause and effects for cancer? Yes. In other words, a lifetime of no fiber and no movement can cause cancer — or smoking three packages a day of cigarettes. But they may not.

But we also know that exposures early in life to certain carcinogens or being born into the wrong family can also be a risk. So, unless you have had cancer, keep your mouth shut about what caused it.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content